Find similar content

Source channel @githubtrending · Post #14965 · Jul 16

#rust#agent#ai#amazon_q#cli#linux#llm#macos#mcp#open_source#productivity#rust#shell#terminal#typescript Amazon Q CLI is a powerful tool that lets you interact with AWS and your development environment using natural language right from your terminal. It helps you write code, run commands, and manage AWS resources faster by understanding your context and providing smart suggestions, autocompletion, and even translating plain English into shell commands. It supports multi-turn conversations, so you can ask follow-up questions and get real-time help without leaving the command line. This boosts your productivity by simplifying complex tasks, reducing errors, and speeding up development workflows, making it easier to manage projects and infrastructure efficiently[1][2][3]. https://github.com/aws/amazon-q-developer-cli

Hashtags

#rust #agent #ai #amazon_q #cli #linux #llm #macos #mcp #open_source #productivity #shell #terminal #typescript

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment